Syriamycin, a new inhibitor for protein synthesis in bacterial & tumour cells.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000096:biosynthesis*; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D002478:Cells, Cultured; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003864:Depression, Chemical; D036341:Intercellular Signaling Peptides and Proteins; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D010455:Peptides / Q000494:pharmacology; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000378:metabolism
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D004273:DNA, Neoplasm; D036341:Intercellular Signaling Peptides and Proteins; D009363:Neoplasm Proteins; D010455:Peptides; C023784:syriamycin